stanford school of medicine logostanford medicine wards

Cardiology

 

Endocrinology

 

Gastroenterology

 

General Inpatient Medicine

 

Hematology

 

Infectious Disease

 

Nephrology

 

Neurology

 

Oncology

 

Outpatient & Preventative Medicine

 

Palliative Care

 

Pulmonary/Critical Care

 

Psychiatry

 

Rheumatology

Post Transplant Lymphoproliferative Disease (PTLD) - Pearls

  • incidence after solid organ tx is highest in lung tx>>heart>>kidney 
  • risk is most related to the degree of immunosuppression and the pt's pre-transplant EBV status
  • pediatric patients are at higher risk, primarily b/c most of them are EBV-negative at time of transplant
  • PTLD is almost always a B-cell neoplasm, and is associate with EBV in >80% of cases
  • PTLD consists of a wide variety of lymphoproliferative diseases.  The WHO classifies them into 3 categories: early lesions (plasmocytic hyperplasia, or mononucleosis-like lesions), monomorphic PTLD: B-cell neoplasms (diffuse large B-cell lymphoma, Burkitt lymphoma, plasma cell myeloma etc.) and polymorphic PTLD (having multiple cell types, often related to primary EBV infxn)

 

(Victoria Kelly MD, 11/2/10)